Treating hydatidiform mole when lung nodules might be metastasis
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at different treatment approaches for hydatidiform mole when a CT scan shows lung nodules and the team cannot rule out spread. It may help guide the safest next steps and follow-up plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of hydatidiform mole confirmed by lab testing (pathology).
- A chest CT showed lung nodules, and doctors cannot rule out that they are related (before or after your uterine procedure).
- Your hCG blood test does not meet criteria for gestational trophoblastic neoplasia (a more severe condition).
- You can follow the study visits and check-ins on a regular schedule.
- You are able and willing to sign informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a hysteroscope (a tiny camera) to gently scrape the uterus again, instead of starting chemotherapy right away, can effectively treat a low-risk, pregnancy-related tumor that returns after a molar pregnancy. It's for Chinese women whose disease is still in an early, low-risk stage.
This study looks at people diagnosed with a hydatidiform mole (a rare pregnancy-related tumor) to understand how it progresses. It follows your health after the mole is removed and checks your hCG levels (a pregnancy hormone) to see if you develop a related condition called post-molar gestational trophoblastic neoplasia.
This study follows people diagnosed with a hydatidiform mole, a rare type of pregnancy growth, to better understand how it progresses and what treatments work best. By participating, you can help improve care for others with this condition.
This study is for people who have a pregnancy-related tumor called gestational trophoblastic disease. It looks at this condition in patients who were diagnosed by blood test (hCG) changes or tissue testing, to better understand and manage the disease.
This study uses ultrasound to check blood flow in the artery that supplies the uterus. The goal is to see if certain measurements can predict whether a complete hydatidiform mole might turn into a more serious condition that needs more treatment.
This trial is creating a database for women diagnosed with gestational trophoblastic neoplasia (GTN), which includes tumors that can develop after a molar pregnancy or other pregnancy-related conditions. By joining, you help researchers better understand and improve treatment for these rare tumors.
Hear when a new Hydatidiform Mole trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.